title: [Gynecomastia: diagnosis and therapy].
authors.affiliation: ENDOKRINOLOGIKUM Hamburg. jens.jacobeit@endokrinologikum.com
authors.forename: J W
authors.initials: JW
authors.lastname: Jacobeit
authors.forename: S
authors.initials: S
authors.lastname: Kliesch
mesh_terms: D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects; D000726:Androgen Antagonists / Q000009:adverse effects; D018567:Breast Neoplasms, Male / Q000175:diagnosis; D002317:Cardiovascular Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D006177:Gynecomastia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007713:Klinefelter Syndrome / Q000150:complications; D007984:Leydig Cell Tumor / Q000150:complications / Q000175:diagnosis; D015187:Lipectomy; D008297:Male; D015414:Mastectomy, Subcutaneous; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000150:complications / Q000175:diagnosis; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy; D011627:Puberty; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D013736:Testicular Neoplasms / Q000150:complications / Q000175:diagnosis; D055815:Young Adult
chemical_list: D045930:Anabolic Agents; D000726:Androgen Antagonists; D002317:Cardiovascular Agents; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen